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Background: Salvia divinorum has known
hallucinogenic effects and is legal in most parts of the
United States. Given that this psychoactive substance
has a potential of misuse and abuse, further data
regarding the clinical and psychosocial factors
associated with use are needed. Objectives: To
examine the clinical and psychosocial characteristics
associated with use of salvia. Methods: The study uses
data from the National Survey on Drug Use and
Health, 2008 (N = 55,623). Results: The results of this
study suggest that salvia use is most common among
young adults aged 18–25 years as well as individuals
who had engaged in risk-taking behaviors (selling
illicit drugs, stealing) or illicit drug use (especially
other hallucinogens/ecstasy). Self-reported depression
and anxiety were also associated with salvia use.
Conclusions/Scientific Significance: The results
provide evidence that salvia use is part of a broader
constellation of psychosocial and behavioral problems
among youth and young adults. The accessibility,
legal status, and psychoactive effects of salvia can be
a potentially complicating health risk to young
people, especially among those with existing
substance use problems.
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INTRODUCTION
Salvia divinorum, commonly referred to as “Diviner’s
Sage” or “salvia,” is a plant from the Mexican Lam-
inaceae mint family that has been known to produce
hallucinogenic effects. The active ingredient in salvia is
the non-alkaloidal hallucinogen salvinorin A, which is
the primary agent for salvia’s psychoactive effects and
regarded as one of the most potent naturally occurring
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hallucinogens (1). Salvia can be taken in different ways,
including chewing the leaves, smoking the leaves in
a rolled cigarette, as concentrated extract administered
sublingually, or smoking in a pipe (2).
A growing body of literature has documented the
effects of salvia, such as depersonalization, laugh-
ter, feelings of levitation, colored visions, loss of
consciousness, déjà vu, and anxiety (2–4). Generally
speaking, effects typically appear within 1 minute of use
and last 15 minutes or less (2), but this varies depending
on the amount used, concentration, and mode of admin-
istration. Doses of purified salvinorin A between 200 and
500 µg have shown intense psychoactive effects (5,6). A
recent clinical study by Johnson and colleagues (7) found
that salvia produced effects having similarities to classic
hallucinogens, including mystical-type effects.
The US Drug Enforcement Administration has iden-
tified salvia as a “drug of concern.” Various states have
attempted to regulate salvia (8). However, under US fed-
eral law, it is not illegal to possess or distribute this
substance, as it is not a controlled substance under the
Controlled Substances Act of 1970 (9). Although salvia
is banned in some places in the United States, salvia can
be easily obtained via the Internet and legally in many
places (e.g., “head shops”) throughout the United States
and abroad (4).
Results from the 2009 Monitoring the Future Survey
revealed that 5.7% of 12th graders reported past-year
use of salvia (10). Although the prevalence of use is
significantly lower compared with other substances such
as marijuana, inhalants, and alcohol, the inclusion of this
measure in this on-going survey is in response to the
increased surveillance need for this substance. Results
from the 2006 National Survey on Drug Use and Health
(NSDUH) showed that about 1.8 million persons aged 12
years or older used salvia in their lifetime, and approxi-
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data also revealed that young adults (18–25 year olds)
were more likely to be past-year users of salvia com-
pared with 12–17 year olds. Males were more likely than
females to be past-year users. In a study of college stu-
dents, Lange et al. (12) found that 4.4% of respondents
used salvia at least once in the past year. Use of salvia
was associated with being white, male, a fraternity mem-
ber, and self-reported heavy episodic drinking (12). A
recent study also showed that salvia use among college
students was more common among white males who
were frequent smokers of marijuana and exhibited low
self-control (13).
Currently, a small body of research exists to docu-
ment the immediate effects of salvia, prevalence of salvia
use, and sociodemographic correlates. However, given
that salvia is a psychoactive substance with potential of
misuse and abuse, further data regarding the clinical and
psychosocial factors associated with use are needed. This
information can help guide the development of targeted
prevention efforts, in addition to providing a stronger
knowledge base for informing regulation of the sub-
stance. This study draws on nationally representative data
to identify important clinical and psychosocial correlates
of salvia use to help fill this gap in knowledge.
METHODS
Data Source
Data were drawn from the 2008 NSDUH public-use
data file (14). NSDUH provides nationally representa-
tive estimates of substance use and related disorders
among civilian, noninstitutionalized US citizens aged 12
years or older. It used multistage area probability sam-
pling methods to identify participants from all 50 US
states and the District of Columbia living in households,
shelters, rooming houses, group homes, and military
bases (15). The multistage sampling design of NSDUH
identifies selected individuals in each state, within strati-
fied blocks and dwelling units, and oversamples adoles-
cents and young adults to improve drug use estimates.
Methodological details on NSDUH are available at http://
www.oas.samhsa.gov/NSDUH/Methods.cfm (accessed
25 January 2011).
Within participants’ place of residence, computer-
assisted interviewing methodology was used in private to
increase the validity of responses regarding substance use
behaviors (12). Field interviewers ensured participants
that responses would be confidential, and procedures
and relevant protections were explained when obtain-
ing informed consent. Participants were offered a $30
incentive for participation in the interview. A total of
68,736 respondents completed interviews in the 2008 sur-
vey. The weighted household screening and interviewing
response rates were 89.0% and 74.4%, respectively (14).
The public-use data file contains 55,739 respondents due
to exclusions to ensure anonymity.
Measures
Adults (≥18 years) and youth (12–17 years) received dif-
ferent surveys in the NSDUH. The following measures
were based on equivalent survey items from both the adult
and youth samples, with the exception of psychosocial
supports and carrying of a handgun (see below), which
were administered only among youth.
Demographics
Participants’ race/ethnicity (non-Hispanic white, non-
Hispanic black, Hispanic, other), age group, gender, and
total family income were examined.
Substance Use
The primary variable, lifetime salvia use, was based
on the following question: “Have you ever, even once,
used S. divinorum?” We assessed whether respondents
reported ever using marijuana, ecstasy, hallucinogens
(lysergic acid diethylamide/LSD, phencyclidine/PCP,
peyote, mescaline, psilocybin), cocaine/crack, or heroin
in their lifetime. It should be noted that past-year salvia
use was not examined due to a low base rate.
Risk-Taking Behaviors and Mental Health
Risk-taking behavior variables were dichotomized (yes or
no) and included past-year selling of illegal drugs, steal-
ing an item worth $50 or more, attacking someone with
the intent to injure, and carrying a handgun (youth sam-
ple only). Two other variables were also used to assess
propensity for risk-taking behaviors: “How often do you
get a real kick out of doing things that are a little dan-
gerous?” and “How often do you like to test yourself by
doing something a little risky?” They had a three-level
response (never, seldom, sometimes/always). Addition-
ally, we examined history of depression and anxiety (i.e.,
whether the respondents were told by a doctor or other
medical professional if they had either of these disorders)
as potential correlates of S. divinorum use.
Prevention-related and Protective Variables
We examined whether youth respondents had ever been
exposed to prevention messages or programs, includ-
ing drug education in school; drug prevention programs
outside of school; seeing or hearing drug prevention mes-
sages outside of school; violence prevention programs;
groups regarding problem solving, communication skills,
or self-esteem; participation in programs to help with
drug abuse; and having ever participated in youth activ-
ities. We also determined whether youth felt that they
could talk with their parents about the dangers of alco-
hol/tobacco/drugs and had someone to talk to about
serious problems.
Analysis
We used Stata version 11.0 to conduct all statistical
analyses and obtain nationally representative estimates
(16). Stata implements a Taylor series linearization to
adjust standard errors based on the stratified sampling
methodology and survey nonresponse. We used weighted
percents to indicate prevalence estimates for all study

























































USE OF SALVIA DIVINORUM 3
ratios (UOR) and adjusted odds ratios (AOR) from logis-
tic regression analyses were used to identify correlates of
lifetime salvia use. We included age, sex, race/ethnicity,
and family income in the adjusted analyses.
RESULTS
Sociodemographics
Table 1 provides prevalence estimates and unadjusted
and adjusted logistic regression analyses for the full
sample, including the sociodemographic, substance use,
psychological, and risk-taking behavior variables. Over-
all, approximately 2.8% of the sample reported lifetime
salvia use, with the highest percentage among persons
aged 18–25 years (6.1%). Unadjusted logistic regression
analyses showed that persons in this age group were 4.12
times more likely to report lifetime salvia use compared
to those aged 12–17 years. The effect size was slightly
attenuated in the adjusted analyses (AOR = 3.93, 95% CI
= 3.25–4.75). Other sociodemographic factors associated
with lifetime salvia use included being male, white, and
having lower levels of family income. These associations
remained significant in adjusted regression analyses.
Substance Use and Psychological Variables
Use of other drugs was consistently associated with
lifetime salvia use. Respondents who were lifetime mar-
ijuana users exhibited the lowest rate of use (3.00%),
whereas lifetime ecstasy users exhibited the highest rate
(13.05%). Unadjusted and adjusted logistic regression
analyses revealed strong associations for each type of
drug. After adjustments, the strongest associations were
observed for lifetime use of hallucinogens (AOR =
19.65) and marijuana (AOR = 27.20). Persons with
depression and anxiety were also more likely to be life-
time users of salvia, although AOR estimates were lower
in comparison to other drug use (AOR = 2.68 and 2.36,
respectively).
Risk-taking Behaviors
Nearly one in five persons (18.59%) who reported selling
illegal drugs had a lifetime history of salvia use. Other
risk-taking behaviors examined also exhibited signifi-
cant associations, although selling illegal drugs exhibited
the largest effect size in the adjusted analysis (AOR =
11.33). A graded relationship across the variables mea-
suring risk propensity was also observed. Persons who
endorsed “sometimes/always” getting a real kick out
of doing dangerous things or liking to test oneself by
doing risky things had the highest percentage of lifetime
salvia use, followed by those who endorsed “seldom” and
“never.” This pattern of association remained significant
in adjusted analyses.
Prevention and Protective Variables
Table 2 summarizes analyses for psychosocial supports
among persons aged 12–17 years. Only two of these
psychosocial support variables assessed exhibited signifi-
cant associations in the unadjusted and adjusted logistic
regression analyses. The adjusted analysis showed that
youth who participated in a drug abuse program were
3.38 times more likely to report lifetime salvia use than
youth who did not participate in a drug abuse program.
Youth who participated in two or more youth activities
were less likely (AOR = .52) to report lifetime salvia use
compared to those who participated in none or only one
youth activity.
DISCUSSION
Although salvia is regarded as one of the most potent nat-
urally occurring hallucinogens (1), very little is known
about the clinical and psychosocial correlates of use. Such
information is important in order to better understand the
extent and patterns of use, which can then help inform
targeted interventions for prevention and drug control
policy. This study, using nationally representative data, is
an initial step toward filling this gap.
The results of this study suggest that salvia use is most
common among young adults aged 18–25 years as well
as individuals who had engaged in risk-taking behaviors
(selling illicit drugs, stealing) or illicit drug use (espe-
cially other hallucinogens/ecstasy). Self-reported depres-
sion and anxiety were also associated with salvia use,
suggesting that some users are affected by mental health
problems. Because this is a cross-sectional study, it is not
possible to determine whether use of salvia is a cause
of these problems (e.g., self-medication hypothesis) or a
consequence of use. Nonetheless, the results provide evi-
dence that salvia use is part of a broader constellation
of psychosocial and behavioral problems among youth
and young adults. The accessibility, legal status, and
psychoactive effects of salvia can be a potentially com-
plicating health risk to young people, especially among
those with existing substance use problems.
Detection of salvia use in routine treatment settings
is problematic, as it is not well known among health-
care providers and current biological drug screens do
not detect this substance. Despite detection challenges,
this study provides an initial understanding of potential
risk factors to guide health-care providers in targeting
assessments. In particular, providers working with youth
and young adults with a history of risk-taking behav-
iors or substance use problems (e.g., cocaine, marijuana,
other hallucinogens) could benefit from further infor-
mation and assessment strategies regarding salvia (5).
Although the abuse liability of salvia is unclear, its psy-
choactive effects and case descriptions of salvia-related
medical complications have been documented (4,17,18).
During treatment, providers should ensure that individ-
uals affected by salvia use are aware of possible health
complications and symptoms (19), despite its status as a
legal substance.
Research to date is not developed enough to inform
strategies for primary prevention. Nonetheless, this study
showed that youth who were involved in two or more
youth activities were less likely to use salvia, which is
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TABLE 1. Lifetime prevalence and correlates of salvia use based on the 2008 National Survey on Drug Use and Health (N = 55,623).
% 95% CI UOR 95% CI AOR 95% CI
Age
12–17 years old (n = 17,777) 1.55 1.32 1.82 1.00 – – 1.00 – –
18–25 years old (n = 19,111) 6.10 5.65 6.58 4.12 3.43 4.94 3.93 3.25 4.75
26–34 years old (n = 5567) 1.74 1.35 2.23 1.12 .83 1.52 1.11 .82 1.50
35 or older (n = 13,168) .15 .09 .24 .09 .06 .16 .08 .05 .14
Sex
Male (n = 26,679) 1.93 1.75 2.12 2.78 2.32 3.32 2.70 2.25 3.24
Female (n = 28,944) .70 .61 .82 1.00 – – 1.00 – –
Race/ethnicity
White (n = 34,483) 1.58 1.45 1.73 1.00 – – 1.00 – –
Black (n = 7,213) .19 .11 .34 .12 .07 .21 .09 .05 .15
Hispanic (n = 9,105) 1.00 .76 1.32 .63 .47 .84 .41 .30 .56
Other (n = 4,822) .95 .67 1.35 .60 .41 .86 .48 .33 .69
Annual family income
Less than $20,000 (n = 11,998) 1.83 1.55 2.16 1.00 – – 1.00 – –
$20,000 – $49,999 (n = 19,010) 1.39 1.21 1.59 .76 .61 .94 .95 .75 1.19
$50,000 – $74,999 (n = 9,954) 1.06 .86 1.31 .58 .44 .76 .71 .53 .94
$75,000 or more (n = 14,661) 1.07 .93 1.24 .58 .47 .73 .80 .63 1.03
Attacked with intent to seriously harm
Yes (n = 2,662) 6.35 5.05 7.94 5.64 4.37 7.29 2.46 1.88 3.22
No (n = 52,831) 1.19 1.09 1.29 1.00 – – 1.00 – –
Sold illegal drugs
Yes (n = 1926) 18.59 16.09 21.37 23.66 19.37 28.90 11.33 9.14 14.04
No (n = 53,526) .96 .87 1.05 1.00 – – 1.00 – –
Stole > $50
Yes (n = 1639) 8.64 6.97 10.66 7.84 6.12 10.06 3.99 3.07 5.19
No (n = 53,838) 1.19 1.09 1.30 1.00 – – 1.00 – –
Ever used ecstasy
Yes (n = 3744) 13.05 11.61 14.63 22.37 18.86 26.53 12.30 10.24 14.79
No (n = 51,879) .67 .60 .74 1.00 – – 1.00 – –
Ever used other hallucinogens
Yes (n = 6008) 6.96 6.28 7.71 16.13 13.54 19.22 19.65 16.22 23.82
No (n = 49,493) .46 .40 .53 1.00 – – 1.00 – –
Ever used cocaine or “crack”
Yes (n = 6584) 5.23 4.67 5.84 8.89 7.54 10.48 11.35 9.44 13.64
No (n = 49,039) .62 .55 .69 1.00 – – 1.00 – –
Ever used marijuana
Yes (n = 21,655) 3.00 2.76 3.25 27.23 17.86 41.50 27.20 17.57 42.10
No (n = 33,968) .11 .08 .17 1.00 – – 1.00 – –
Ever used heroin
Yes (n = 717) 9.47 7.24 12.31 8.84 6.51 12.00 9.93 6.94 14.22
No (n = 54,906) 1.17 1.08 1.27 1.00 – – 1.00 – –
Lifetime depression
Yes (n = 5436) 2.26 1.88 2.72 1.97 1.60 2.43 2.68 2.13 3.38
No (n = 48,873) 1.16 1.06 1.27 1.00 – – 1.00 – –
Lifetime anxiety
Yes (n = 3438) 2.31 1.88 2.84 1.93 1.54 2.43 2.36 1.85 3.01
No (n = 50,871) 1.21 1.11 1.32 1.00 – – 1.00 – –
Getting a real kick out of doing dangerous things
Never (n = 21,772) .18 .13 .25 1.00 – – 1.00 – –
Seldom (n = 17,161) 1.24 1.06 1.45 7.11 4.90 10.33 3.64 2.54 5.22
Sometimes/always (n = 16,319) 4.39 3.99 4.84 26.01 18.28 37.01 8.72 6.15 12.35
Like to test yourself by doing risky things
Never (n = 21,693) .26 .19 .34 1.00 – – 1.00 – –
Seldom (n = 19,869) 1.44 1.26 1.63 5.68 4.18 7.70 3.06 2.27 4.14
Sometimes/always (n = 13,841) 4.19 3.75 4.68 17.04 12.63 22.99 5.98 4.39 8.14
Notes: CI, confidence interval; UOR, unadjusted odds ratio; AOR, adjusted odds ratio. All percentages are reported as row percentages and
weighted estimates. Adjusted analyses included age, sex, race, and income. Values in bold are statistically significant based on a 95% CI that
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TABLE 2. Risk and preventive factors associated with lifetime salvia use among youth (ages 12–17 years) based on the 2008 National
Survey of Drug Use and Health (N = 17,777).
% 95% CI UOR 95% CI AOR 95% CI
Talk with about serious problems
Someone (n = 16,838) 1.51 1.28 1.79 .59 .30 1.14 .55 .28 1.07
No one (n = 588) 2.56 1.36 4.75 1.00 – – 1.00 – –
Talk with parent about danger of tobacco, alcohol, or drugs
Yes (n = 10,361) 1.65 1.36 2.01 1.19 .84 1.70 1.12 .78 1.59
No (n = 7,208) 1.39 1.04 1.85 1.00 – – 1.00 – –
Participated in problem solving/communication
skills/self-esteem group
Yes (n = 3,928) 1.53 1.06 2.22 .98 .64 1.49 1.01 .66 1.55
No (n = 13,488) 1.57 1.31 1.88 1.00 – – 1.00 – –
Participated in violence prevention program
Yes (n = 2,531) 1.82 1.15 2.85 1.22 .74 2.00 1.38 .84 2.27
No (n = 15,072) 1.50 1.26 1.78 1.00 – – 1.00 – –
Participated in drug prevention program outside school
Yes (n = 1,970) 1.87 1.19 2.92 1.25 .77 2.05 1.31 .79 2.18
No (n = 15,666) 1.49 1.26 1.78 1.00 – – 1.00 – –
Participated in program to help drug abuse
Yes (n = 786) 3.90 2.39 6.31 2.79 1.63 4.77 3.38 1.93 5.90
No (n = 16,805) 1.43 1.21 1.70 1.00 – – 1.00 – –
Participated in youth activities
2 or more activities (n = 14,985) 1.38 1.15 1.65 .56 .38 .84 .52 .34 .78
None or 1 activity (n = 2,721) 2.43 1.72 3.42 1.00 – – 1.00 – –
Youth seen drug prevention messages outside of school
Yes (n = 13,744) 1.65 1.38 1.97 1.45 .92 2.27 1.40 .90 2.18
No (n = 3,831) 1.15 .76 1.73 1.00 – – 1.00 – –
Youth had any drug education in school
Yes (n = 12,532) 1.42 1.16 1.73 .70 .50 1.00 .70 .49 1.00
No (n = 3,949) 2.00 1.52 2.63 1.00 – – 1.00 – –
Carried a handgun
Yes (n = 626) 3.77 2.32 6.07 2.65 1.56 4.49 2.22 1.28 3.86
No (n = 17,078) 1.46 1.23 1.73 1.00 – – 1.00 – –
Notes: CI, confidence interval; UOR, unadjusted odds ratio; AOR, adjusted odds ratio. All percentages are reported as row percentages and
weighted estimates. Adjusted analyses included age, sex, race, and income. Values in bold are statistically significant based on a 95% CI that
does not bound the value 1.00.
development (19,20). This suggests that a social net-
work approach may be particularly useful to inform youth
of the possible negative consequences of use and offer
meaningful recreational and social opportunities. How-
ever, the existing research, albeit limited, also suggests
the role of the Internet as a mechanism for obtaining
information and the actual substance. For example, videos
of youth and young adults using salvia can easily be found
on YouTube (17). At the time of this study, some videos
showing salvia trips, especially those that characterize
salvia in a favorable way, have been viewed over 1 million
times. In a recent study, salvia was endorsed by more than
75% of the salvia-associated websites examined, whereas
only 2% were classified as anti-use/treatment informa-
tion websites (9). Thus, as knowledge of salvia continues
to develop, it is important to consider effective uses
of the Internet to disseminate educational or preventive
information that may counter potentially inappropriate
information sources.
These results should be considered in the context of
its limitations. As indicated, we are unable to estab-
lish causal associations among the relationships identified
in this study. Additionally, the survey did not contain
data on amount of use, frequency of use, and mode of
administration. These are important factors that could
change the nature of the relationships. Future research
that includes detailed assessment of patterns of use,
reasons for initiation, and effects of use is needed to
develop effective prevention, assessment, and treatment
strategies.
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